FEG
GMOV

Fund Evaluation Group’s GMO US Value ETF GMOV Stock Holding History

Fund Evaluation Group’s Portfolio GMOV Stock Details GMOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Buy
80,000
+29,500
+58% +$841K 0.07% 46
2025
Q4 		$1.39M Buy
50,500
+3,500
+7% +$93.6K 0.05% 42
2025
Q3 		$1.24M Buy
+47,000
New +$1.22M 0.05% 54

Other funds holding GMOV

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
LCWP
Legacy Capital Wealth Partners Little Rock, Arkansas $485M AUM 21.24% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $297M AUM 40.85% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
CA
Commerce Advisors Memphis, Tennessee $119M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Fund Evaluation Group's GMOV Position: Q1 2026 in Review

Fund Evaluation Group increased its GMO US Value ETF (GMOV) stake by 58% in Q1 2026, buying an estimated $841K and bringing the position to 80,000 shares worth $2.25M. The position accounts for 0.07% of the portfolio, ranked #46.

Fund Evaluation Group first reported a position in GMOV in Q3 2025 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold GMOV as of Q1 2026.

  • Fund Evaluation Group held 80,000 shares of GMO US Value ETF worth $2.25M as of Q1 2026.
  • Fund Evaluation Group bought 29,500 GMO US Value ETF shares in Q1 2026, an estimated $841K.
  • GMO US Value ETF made up 0.07% of Fund Evaluation Group's portfolio in Q1 2026, its #46 holding.
  • Fund Evaluation Group first reported a position in GMO US Value ETF in Q3 2025 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held GMO US Value ETF as of Q1 2026.

Based on Fund Evaluation Group's 13F filing for Q1 2026, filed 8 May 2026.